Celltrion’s Xolair Biosimilar Reaches UK, Following Key US Filing

Korean Firm Obtained Pan-European Marketing Authorization For Omalizumab In May

 
• By Dean Rudge

Celltrion has ticked off another major regulator as it continues to lead the pack of global developers for biosimilar Xolair.

uk flag close up
• Source: Shutterstock

More from Biosimilars

More from Products